rs4986790
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_138554.5(TLR4):c.896A>G(p.Asp299Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0625 in 1,613,856 control chromosomes in the GnomAD database, including 3,677 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.066 ( 378 hom., cov: 32)
Exomes 𝑓: 0.062 ( 3299 hom. )
Consequence
TLR4
NM_138554.5 missense
NM_138554.5 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 2.66
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0037297606).
BP6
Variant 9-117713024-A-G is Benign according to our data. Variant chr9-117713024-A-G is described in ClinVar as [Benign]. Clinvar id is 6660.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr9-117713024-A-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLR4 | NM_138554.5 | c.896A>G | p.Asp299Gly | missense_variant | 3/3 | ENST00000355622.8 | NP_612564.1 | |
TLR4 | NM_003266.4 | c.776A>G | p.Asp259Gly | missense_variant | 4/4 | NP_003257.1 | ||
TLR4 | NM_138557.3 | c.296A>G | p.Asp99Gly | missense_variant | 2/2 | NP_612567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLR4 | ENST00000355622.8 | c.896A>G | p.Asp299Gly | missense_variant | 3/3 | 1 | NM_138554.5 | ENSP00000363089 | P1 | |
TLR4 | ENST00000394487.5 | c.776A>G | p.Asp259Gly | missense_variant | 4/4 | 1 | ENSP00000377997 | |||
TLR4 | ENST00000472304.2 | c.*630A>G | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000496429 |
Frequencies
GnomAD3 genomes AF: 0.0660 AC: 10044AN: 152074Hom.: 378 Cov.: 32
GnomAD3 genomes
AF:
AC:
10044
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0605 AC: 15187AN: 250890Hom.: 584 AF XY: 0.0629 AC XY: 8525AN XY: 135586
GnomAD3 exomes
AF:
AC:
15187
AN:
250890
Hom.:
AF XY:
AC XY:
8525
AN XY:
135586
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0621 AC: 90797AN: 1461664Hom.: 3299 Cov.: 32 AF XY: 0.0632 AC XY: 45973AN XY: 727140
GnomAD4 exome
AF:
AC:
90797
AN:
1461664
Hom.:
Cov.:
32
AF XY:
AC XY:
45973
AN XY:
727140
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0660 AC: 10042AN: 152192Hom.: 378 Cov.: 32 AF XY: 0.0684 AC XY: 5088AN XY: 74394
GnomAD4 genome
AF:
AC:
10042
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
5088
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
183
ALSPAC
AF:
AC:
195
ESP6500AA
AF:
AC:
314
ESP6500EA
AF:
AC:
517
ExAC
AF:
AC:
7267
Asia WGS
AF:
AC:
221
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
COPD, severe early onset Pathogenic:1
Likely risk allele, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | Sep 01, 2023 | Allele associated with the development of COPD secondary to tobacco smoke - |
Susceptibility to severe coronavirus disease (COVID-19) Uncertain:1
Uncertain significance, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | - | - - |
TLR4 POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Sep 01, 2007 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Pericementitis Benign:1
protective, no assertion criteria provided | case-control | OsteoImmunology Lab, Universidade de Sao Paulo | Dec 03, 2018 | In an exploratory population (N=570, 186 cases/ 384 controls), rs4986790 demonstrated a significant protective effect for the phenotype of chronic periodontitis [OR 0.3315, CI 0.14-0.75, p-value 0.005] . The association analysis combining the exploratory and three independent validation populations (N=1410; 528 cases and 882 controls) demonstrated a significant protective effect of the polymorphic allele for the phenotype ‘susceptibility for inflammatory alveolar bone resorption’ [OR 0.57, CI 0.38-0.85, p-value 0.005]. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
A;A
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;.;T
Polyphen
0.026
.;B;B
Vest4
MPC
0.11
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at